In accordance with previous studies, we speculate that pre-treatment with rapamycin inhibits mTORC1 activation in KCs rather than in hepatocytes, and the loss of KCs might represent a protective event in the early stage of acute hepatitis to alleviate the inflammatory response. The gene discussed is TBCE; the disease is Acute hepatitis.